Clinical Trial Update: Validation of the TheraSure CNI-Monitor Under Immuno-checkpoint-therapy (Hereinafter: "Immunotherapy") in NSCLC in Palliative Therapy

View source ↗

Summary

This entry reports a trial validating the TheraSure CNI-Monitor in non-small cell lung cancer patients undergoing immunotherapy in palliative care; recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Karsten Gavenis | Conditions: NSCLC | Status: RECRUITING